EFFICACY OF TAZAROTENE 0.1% GEL VERSUS ISOTRETINOIN 0.05% GEL IN THE TREATMENT OF FACIAL ACNE VULGARIS
DOI:
https://doi.org/10.33279/jkcd.v13i2.576Keywords:
Effi cacy, Tazarotene 0.1% gel, Isotretinoin 0.05% gel, facial acne vulgaris, Percent facial acne lesions scoreAbstract
Objectives: To compare the eff ect of isotretinoin 0.05% gel vs tazarotene 0.1% gel in reducing the percent facial acne score for the management of acne vulgaris.
Materials and Methods: The randomized controlled study was conducted at the Lady Reading Hospital in Peshawar's Department of Dermatology from January 3, 2020, to January 10, 2020 A total of 114 subjects were carefully selected and randomly divided into two groups (57 in each group). Every single patient had thorough medical evaluations and history assessments. While those participating in group B received topical isotretinoin 0.05% gel three times per day, those in group A received topical tazarotene gel 0.1% three times each day. Scores on the Acne Global Severity Scale and the percentage of facial acne lesions were taken at baseline and the conclusion of treatment. Following the conclusion of therapy, all patients will be followed up with 4 weeks later. To analyze the data, SPSS was used. Chi-square test was used to compared treatment effi -cacy between the two groups.
Results: In group A, the mean age was 18±2.6 years, but group B mean age was almost 19.4±4.4 years. In group A, 57% of the individuals were female, while 43% of participants were males. In Group B, nevertheless there were 60% female participants and 40% male patients. 38 (66%) of the participants in group A (tazarotene) demonstrated effi cacy employing the percent facial acne lesion score. On the other hand, isotretinoin (Group B) was successful in 27 (48%) of the patients.
Conclusion:During managing acne vulgaris on the face, tazarotene 0.1% gel performs more effectively than isotretinoin 0.05% gel.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 AYESHA JAMIL, GHAFOOR ULLAH, FARHAD ALI, SIDRA SHABBIR
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
